Advertisement
Advertisement
U.S. markets close in 1 hour 7 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Dermapharm Holding SE (DMP.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
85.20+0.55 (+0.65%)
At close: 5:35PM CEST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in EUR

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/19/2021
Current
6/30/20213/31/202112/31/20209/30/2020
Market Cap (intraday) 5
4.57B3.62B3.30B3.09B2.42B
Enterprise Value 3
5.08B4.10B3.82B3.61B2.94B
Trailing P/E
37.0838.2141.2238.4932.11
Forward P/E 1
22.4721.5122.2723.9220.28
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
5.414.474.334.043.29
Price/Book (mrq)
12.5610.1011.0510.328.93
Enterprise Value/Revenue 3
6.0219.0417.9916.6514.79
Enterprise Value/EBITDA 7
21.6455.2560.6969.5663.42

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 389.99%
S&P500 52-Week Change 330.30%
52 Week High 389.05
52 Week Low 340.78
50-Day Moving Average 383.12
200-Day Moving Average 373.41

Share Statistics

Avg Vol (3 month) 348.5k
Avg Vol (10 day) 354.23k
Shares Outstanding 553.84M
Implied Shares Outstanding 6N/A
Float 818.82M
% Held by Insiders 165.05%
% Held by Institutions 118.33%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.88
Forward Annual Dividend Yield 41.04%
Trailing Annual Dividend Rate 30.88
Trailing Annual Dividend Yield 31.04%
5 Year Average Dividend Yield 4N/A
Payout Ratio 438.60%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 24, 2021
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2020
Most Recent Quarter (mrq)Jun 30, 2021

Profitability

Profit Margin 14.37%
Operating Margin (ttm)22.35%

Management Effectiveness

Return on Assets (ttm)9.67%
Return on Equity (ttm)37.96%

Income Statement

Revenue (ttm)858.15M
Revenue Per Share (ttm)15.89
Quarterly Revenue Growth (yoy)15.80%
Gross Profit (ttm)453.89M
EBITDA 208.49M
Net Income Avi to Common (ttm)123.32M
Diluted EPS (ttm)2.28
Quarterly Earnings Growth (yoy)232.60%

Balance Sheet

Total Cash (mrq)105.39M
Total Cash Per Share (mrq)1.96
Total Debt (mrq)612.8M
Total Debt/Equity (mrq)167.99
Current Ratio (mrq)2.69
Book Value Per Share (mrq)6.73

Cash Flow Statement

Operating Cash Flow (ttm)164.22M
Levered Free Cash Flow (ttm)89.88M
Advertisement
Advertisement